Leucosceptoside A
Modify Date: 2024-01-11 08:14:36
Leucosceptoside A structure
|
Common Name | Leucosceptoside A | ||
|---|---|---|---|---|
| CAS Number | 83529-62-8 | Molecular Weight | 638.61400 | |
| Density | 1.545g/cm3 | Boiling Point | 884.547ºC at 760 mmHg | |
| Molecular Formula | C30H38O15 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 283.993ºC | |
Use of Leucosceptoside ALeucosceptoside A is a phenylethanoid glycoside with anti-hyperglycemic and anti-hypertensive activities. Leucosceptoside A shows inhibitory activity against α-glucosidase and PKCα (IC50 of 19.0 μM)[1][2][3]. |
| Name | [(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoate |
|---|
| Description | Leucosceptoside A is a phenylethanoid glycoside with anti-hyperglycemic and anti-hypertensive activities. Leucosceptoside A shows inhibitory activity against α-glucosidase and PKCα (IC50 of 19.0 μM)[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
PKCα:19 μM (IC50) |
| In Vitro | Leucosceptoside A shows weak angiotensin converting enzyme (ACE) inhibitory effect[1]. Leucosceptoside A (4-16 μM) significantly reduces 1-methyl-4-phenylpyridinium ion (MPP+)-induced death of mesencephalic neurons[2]. |
| References |
| Density | 1.545g/cm3 |
|---|---|
| Boiling Point | 884.547ºC at 760 mmHg |
| Molecular Formula | C30H38O15 |
| Molecular Weight | 638.61400 |
| Flash Point | 283.993ºC |
| Exact Mass | 638.22100 |
| PSA | 234.29000 |
| Index of Refraction | 1.664 |